Meno Plus is a food supplement designed to support women during perimenopause and menopause, helping to improve their general well-being.

Its formulation combines plant extracts traditionally used during this stage of ife, such as soya isoflavones, black cohosh and dong quai, which are known for their use in relieving symptoms associated with the menopause, such as hot flushes, night sweats and mood swings.

The formulation is rounded off with borage extract, which helps to maintain the skin’s moisture levels and comfort, and vitamin E, which has antioxidant properties that help protect cells against oxidative damage.

Composition

Soy germ (dry extract of Glycine max L., 40% isoflavones); black cohosh (dry extract of Cimicifuga racemosa); dong quai (dry extract of Angelica sinensis); borage (dry extract of Borago officinalis); vitamin E (DL-alpha tocopheryl acetate).

Other components

Envelope [gelatin, colourant (calcium carbonate)]; bulking agent (microcrystalline cellulose); anti-agglomerating agent (magnesium salts of fatty acids).

How to use

Bulking agent (microcrystalline cellulose); anti-agglomerating agent (magnesium stearate, silicon dioxide).

Ingredient summary per dose

*NRVs: Nutrient Reference Values.

Presentation

45 tablets.

Warnings

Food supplements must not be used as a substitute for a varied and balanced diet and a healthy lifestyle.
Do not exceed the specifically recommended daily dose.
Keep out of reach and sight of the youngest children.
Store in a cool place, below 30 ºC.

Bibliography

Abdi F, Alimoradi Z, Haqi P, Mahdizad F. Effects of phytoestrogens on bone mineral density during the menopause transition: a systematic review of randomized, controlled trials. Climacteric 2016; 19 (6): 535-545.

Howes LG, Howes JB, Knight DC. Isoflavone therapy for menopausal flushes: A systematic review and meta-analysis. Maturitas 2006; 55: 203-211.

Borrelli F, Ernst E. Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacy. Pharmacol Res. 2008; 58 (1): 8-14. doi: 10.1016/j.phrs.2008.05.008.

Meno Plus es un complemento alimenticio formulado para apoyar a la mujer durante la perimenopausia y menopausia, ayudando a mejorar su bienestar general.

Su composición combina extractos vegetales tradicionalmente utilizados durante esta etapa de la vida, como isoflavonas de soja, cimicífuga y dong quai, conocidos por su uso en el alivio de molestias asociadas a la menopausia, como los sofocos, la sudoración o los cambios de ánimo.

La fórmula se completa con extracto de borraja, que ayuda a mantener la hidratación y el confort de la piel, y vitamina E, con acción antioxidante que contribuye a la protección celular frente al daño oxidativo.

Composición

Germen de soja (extracto seco de Glycine max L., 40 % isoflavonas); cimicífuga (extracto seco de Cimicifuga racemosa); dong quai (extracto seco de Angelica sinensis); borraja (extracto seco de Borago officinalis); vitamina E (acetato de DL-alfa-tocoferilo).

Otros componentes

Agente de carga (celulosa microcristalina); antiaglomerante (estearato de magnesio y dióxido de silicio).

Modo de empleo

Tomar un comprimido con el desayuno y otro con la cena.

Ingredientes por toma

*VRN: Valores de Referencia de Nutrientes.

Presentación

45 comprimidos.

Advertencias

Los complementos alimenticios no deben utilizarse como sustitutos de una dieta variada y equilibrada y por un modo de vida sano.
No superar la dosis diaria expresamente recomendada.
Mantener fuera del alcance de los niños más pequeños.
Mantener en lugar fresco, por debajo de 30 ºC.

Referencias bibliográficas

Abdi F, Alimoradi Z, Haqi P, Mahdizad F. Effects of phytoestrogens on bone mineral density during the menopause transition: a systematic review of randomized, controlled trials. Climacteric 2016; 19 (6): 535-545.

Howes LG, Howes JB, Knight DC. Isoflavone therapy for menopausal flushes: A systematic review and meta-analysis. Maturitas 2006; 55: 203-211.

Borrelli F, Ernst E. Black cohosh (Cimicifuga racemosa) for menopausal symptoms: a systematic review of its efficacy. Pharmacol Res. 2008; 58 (1): 8-14. doi: 10.1016/j.phrs.2008.05.008.